Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Cash from Investing Activities: 2020-2025

Historic Cash from Investing Activities for Molecular Partners Ag (MOLN) over the last 5 years, with Sep 2025 value amounting to -$62.3 million.

  • Molecular Partners Ag's Cash from Investing Activities fell 75.86% to -$62.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.1 million, marking a year-over-year decrease of 9.67%. This contributed to the annual value of $46.0 million for FY2024, which is 7.40% down from last year.
  • Molecular Partners Ag's Cash from Investing Activities amounted to -$62.3 million in Q3 2025, which was down 203.44% from $60.3 million recorded in Q2 2025.
  • In the past 5 years, Molecular Partners Ag's Cash from Investing Activities registered a high of $113.3 million during Q3 2022, and its lowest value of -$113.7 million during Q2 2022.
  • Its 3-year average for Cash from Investing Activities is $8.4 million, with a median of $38,888 in 2025.
  • The largest annual percentage gain for Molecular Partners Ag's Cash from Investing Activities in the last 5 years was 1,175.75% (2022), contrasted with its biggest fall of 22,331.62% (2022).
  • Molecular Partners Ag's Cash from Investing Activities (Quarterly) stood at -$24.1 million in 2021, then plummeted by 335.29% to -$104.8 million in 2022, then surged by 147.98% to $50.3 million in 2023, then dropped by 8.21% to $46.2 million in 2024, then plummeted by 75.86% to -$62.3 million in 2025.
  • Its last three reported values are -$62.3 million in Q3 2025, $60.3 million for Q2 2025, and $38,888 during Q1 2025.